
Alison W Loren MD
Hematologic Oncology
Assistant Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Civic Center Blvd6th Floor South TowerPhiladelphia, PA 19104
Phone+1 215-662-2406
Dr. Loren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 2000
- Washington University in St. Louis School of MedicineClass of 1996
Certifications & Licensure
- PA State Medical License 1997 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.Margaret Rowe, Daria Babushok, Martin Carroll, Alison Carulli, Noelle Frey
European Journal of Haematology. 2025-04-01 - Fertility Preservation in People With Cancer: ASCO Guideline Update.H Irene Su, Christina Lacchetti, Joseph Letourneau, Ann H Partridge, Rubina Qamar
Journal of Clinical Oncology. 2025-03-19 - Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko
Journal of Clinical Oncology. 2025-03-10
Journal Articles
- Harder to Treat Than Leukemia — Opioid Use Disorder in Survivors of CancerAlison Loren, MD, The New England Journal of Medicine
Press Mentions
- Penn Medicine at the 2024 ASH Annual MeetingDecember 2nd, 2024
- Penn Medicine at the 2022 ASH MeetingDecember 8th, 2022
- New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease After Stem Cell TransplantationJanuary 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: